Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Covid-19 Cytokine Storm Complications in Asthmatic Patients Publisher



Nasab EM1 ; Athari SS2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

Source: Open Public Health Journal Published:2020


Abstract

The pandemic of coronavirus disease 2019 has inflicted millions of people in the world and caused severe complications in immunocompromised individuals. Some evidences suggest that severe COVID-19 complications are associated with the cytokine storm syndrome, contributing to the high mortality rate of the disease. Asthma is a complicated disease of the respiratory system. COVID-19 symptoms can be worse in asthmatic patients than others. Corticosteroids with anti-inflammatory functions which are used in asthmatic patients may have adverse outcomes in coronavirus infection and are not recommended for the treatment of COVID-19. Furthermore, asthmatic patients (using inhalation corticosteroids) have a suppressed immune system in the lung, which increases their susceptibility to COVID-19 infection. © 2020 Nasab & Athari.
Other Related Docs
14. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
20. Role of Il-4 in Cytokine Storm Syndrome Due to Covid-19 Infection, Journal of Cellular and Molecular Anesthesia (2020)
22. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
27. A Review on Hematologic Malignant Patients Infected With 2019 Novel Coronavirus, Archives of Clinical Infectious Diseases (2020)
31. Tocilizumab in Icu-Admitted Covid-19 Patients: A Retrospective Study, Medical Journal of the Islamic Republic of Iran (2023)
35. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
47. Jak Inhibition As a New Treatment Strategy for Patients With Covid-19, International Archives of Allergy and Immunology (2020)
49. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)